Ngā hua rapu kaituhi

1

Tumours outside the mutation box mā Rogier Versteeg

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
2

c-myc down-regulates class I HLA expression in human melanomas. mā Rogier Versteeg, IA Noordermeer, M. Krüse-Wolters, D. J. Ruiter, Peter I. Schrier

I whakaputaina 1988

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression mā Fieke Lamers, Linda Schild, Jan Köster, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Regulation of Type III Iodothyronine Deiodinase Expression in Human Cell Lines mā Monique H. A. Kester, George G. J. M. Kuiper, Rogier Versteeg, Theo J. Visser

I whakaputaina 2006

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene mā Gerben Schaaf, Mohamed Hamdi, Danny A. Zwijnenburg, Arjan Lakeman, Dirk Geerts, Rogier Versteeg, Marcel Kool

I whakaputaina 2010

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma mā Evan E. Santo, Peter Stroeken, Peter van Sluis, Jan Köster, Rogier Versteeg, Ellen M. Westerhout

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma mā Johan van Nes, Alvin Chan, Tim van Groningen, Peter van Sluis, Jan Köster, Rogier Versteeg

I whakaputaina 2013

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells mā Jens Bunt, Nancy E. Hasselt, Danny A. Zwijnenburg, Mohamed Hamdi, Jan Köster, Rogier Versteeg, Marcel Kool

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness mā Flora Cimmino, Johannes H. Schulte, Massimo Zollo, Jan Köster, Rogier Versteeg, Achille Iolascon, Angelika Eggert, Alexander Schramm

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Discovery and visualization of miRNA–mRNA functional modules within integrated data using bicluster analysis mā Kenneth Bryan, Marta Terrile, Isabella Bray, Raquel Domingo-Fernandéz, Karen M. Watters, Jan Köster, Rogier Versteeg, Raymond L. Stallings

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

A top-down analysis of Xa- and Xi-territories reveals differences of higher order structure at ≥ 20 Mb genomic length scales mā Kathrin Teller, Doris Illner, Stefanie Thamm, Corella S. Casas-Delucchi, Rogier Versteeg, Mireille H. G. Indemans, Thomas Cremer, Marion Cremer

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma mā Janine Stutterheim, Lily Zappeij‐Kannegieter, Rogier Versteeg, H.N. Caron, C. Ellen van der Schoot, Godelieve A.M. Tytgat

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Domain-wide regulation of gene expression in the human genome mā Hinco J. Gierman, Mireille H. G. Indemans, Jan Köster, Sandra Goetze, Jurgen Seppen, Dirk Geerts, Roel van Driel, Rogier Versteeg

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma mā Jan J. Molenaar, Marli E. Ebus, Jan Köster, Peter van Sluis, Carel J.M. van Noesel, Rogier Versteeg, Huib N. Caron

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

N-ras mutations in human cutaneous melanoma from sun-exposed body sites. mā Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

I whakaputaina 1989

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells mā Jan J. Molenaar, Marli E. Ebus, Dirk Geerts, Jan Köster, Fieke Lamers, Linda J. Valentijn, Ellen M. Westerhout, Rogier Versteeg, Huib N. Caron

I whakaputaina 2009

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. mā Rogier Versteeg, K M Krüse-Wolters, Arianne C. Plomp, A. van Leeuwen, Nico J. Stam, Hidde L. Ploegh, D. J. Ruiter, Peter I. Schrier

I whakaputaina 1989

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification mā Dirk Geerts, Jan Köster, D.J. Albert, Dana‐Lynn T. Koomoa, David J. Feith, Anthony E. Pegg, Richard Volckmann, Huib N. Caron, Rogier Versteeg, André S. Bachmann

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification mā Linda J. Valentijn, Jan Köster, Franciska Haneveld, Rachida Ait Aissa, Peter van Sluis, Marloes E.C. Broekmans, Jan J. Molenaar, Johan van Nes, Rogier Versteeg

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

The Human Transcriptome Map Reveals Extremes in Gene Density, Intron Length, GC Content, and Repeat Pattern for Domains of Highly and Weakly Expressed Genes mā Rogier Versteeg, Barbera D. C. van Schaik, Marinus F. van Batenburg, Marco Roos, Ramin Monajemi, Huib N. Caron, Harmen J. Bussemaker, Antoine H. C. van Kampen

I whakaputaina 2003

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Tumours outside the mutation box mā Rogier Versteeg

c-myc down-regulates class I HLA expression in human melanomas. mā Rogier Versteeg, IA Noordermeer, M. Krüse-Wolters, D. J. Ruiter, Peter I. Schrier

Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression mā Fieke Lamers, Linda Schild, Jan Köster, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar

Regulation of Type III Iodothyronine Deiodinase Expression in Human Cell Lines mā Monique H. A. Kester, George G. J. M. Kuiper, Rogier Versteeg, Theo J. Visser

Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene mā Gerben Schaaf, Mohamed Hamdi, Danny A. Zwijnenburg, Arjan Lakeman, Dirk Geerts, Rogier Versteeg, Marcel Kool

FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma mā Evan E. Santo, Peter Stroeken, Peter van Sluis, Jan Köster, Rogier Versteeg, Ellen M. Westerhout

A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma mā Johan van Nes, Alvin Chan, Tim van Groningen, Peter van Sluis, Jan Köster, Rogier Versteeg

OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells mā Jens Bunt, Nancy E. Hasselt, Danny A. Zwijnenburg, Mohamed Hamdi, Jan Köster, Rogier Versteeg, Marcel Kool

Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness mā Flora Cimmino, Johannes H. Schulte, Massimo Zollo, Jan Köster, Rogier Versteeg, Achille Iolascon, Angelika Eggert, Alexander Schramm

Discovery and visualization of miRNA–mRNA functional modules within integrated data using bicluster analysis mā Kenneth Bryan, Marta Terrile, Isabella Bray, Raquel Domingo-Fernandéz, Karen M. Watters, Jan Köster, Rogier Versteeg, Raymond L. Stallings

A top-down analysis of Xa- and Xi-territories reveals differences of higher order structure at ≥ 20 Mb genomic length scales mā Kathrin Teller, Doris Illner, Stefanie Thamm, Corella S. Casas-Delucchi, Rogier Versteeg, Mireille H. G. Indemans, Thomas Cremer, Marion Cremer

The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma mā Janine Stutterheim, Lily Zappeij‐Kannegieter, Rogier Versteeg, H.N. Caron, C. Ellen van der Schoot, Godelieve A.M. Tytgat

Domain-wide regulation of gene expression in the human genome mā Hinco J. Gierman, Mireille H. G. Indemans, Jan Köster, Sandra Goetze, Jurgen Seppen, Dirk Geerts, Roel van Driel, Rogier Versteeg

Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma mā Jan J. Molenaar, Marli E. Ebus, Jan Köster, Peter van Sluis, Carel J.M. van Noesel, Rogier Versteeg, Huib N. Caron

N-ras mutations in human cutaneous melanoma from sun-exposed body sites. mā Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells mā Jan J. Molenaar, Marli E. Ebus, Dirk Geerts, Jan Köster, Fieke Lamers, Linda J. Valentijn, Ellen M. Westerhout, Rogier Versteeg, Huib N. Caron

Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. mā Rogier Versteeg, K M Krüse-Wolters, Arianne C. Plomp, A. van Leeuwen, Nico J. Stam, Hidde L. Ploegh, D. J. Ruiter, Peter I. Schrier

Functional MYCN signature predicts outcome of neuroblastoma irrespective of <i>MYCN</i> amplification mā Linda J. Valentijn, Jan Köster, Franciska Haneveld, Rachida Ait Aissa, Peter van Sluis, Marloes E.C. Broekmans, Jan J. Molenaar, Johan van Nes, Rogier Versteeg

Ngā hua rapu - Rogier Versteeg

Tumours outside the mutation box mā Rogier Versteeg

c-myc down-regulates class I HLA expression in human melanomas. mā Rogier Versteeg, IA Noordermeer, M. Krüse-Wolters, D. J. Ruiter, Peter I. Schrier

Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression mā Fieke Lamers, Linda Schild, Jan Köster, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar

Regulation of Type III Iodothyronine Deiodinase Expression in Human Cell Lines mā Monique H. A. Kester, George G. J. M. Kuiper, Rogier Versteeg, Theo J. Visser

Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene mā Gerben Schaaf, Mohamed Hamdi, Danny A. Zwijnenburg, Arjan Lakeman, Dirk Geerts, Rogier Versteeg, Marcel Kool

FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma mā Evan E. Santo, Peter Stroeken, Peter van Sluis, Jan Köster, Rogier Versteeg, Ellen M. Westerhout

A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma mā Johan van Nes, Alvin Chan, Tim van Groningen, Peter van Sluis, Jan Köster, Rogier Versteeg

OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells mā Jens Bunt, Nancy E. Hasselt, Danny A. Zwijnenburg, Mohamed Hamdi, Jan Köster, Rogier Versteeg, Marcel Kool

Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness mā Flora Cimmino, Johannes H. Schulte, Massimo Zollo, Jan Köster, Rogier Versteeg, Achille Iolascon, Angelika Eggert, Alexander Schramm

Discovery and visualization of miRNA–mRNA functional modules within integrated data using bicluster analysis mā Kenneth Bryan, Marta Terrile, Isabella Bray, Raquel Domingo-Fernandéz, Karen M. Watters, Jan Köster, Rogier Versteeg, Raymond L. Stallings

A top-down analysis of Xa- and Xi-territories reveals differences of higher order structure at ≥ 20 Mb genomic length scales mā Kathrin Teller, Doris Illner, Stefanie Thamm, Corella S. Casas-Delucchi, Rogier Versteeg, Mireille H. G. Indemans, Thomas Cremer, Marion Cremer

The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma mā Janine Stutterheim, Lily Zappeij‐Kannegieter, Rogier Versteeg, H.N. Caron, C. Ellen van der Schoot, Godelieve A.M. Tytgat

Domain-wide regulation of gene expression in the human genome mā Hinco J. Gierman, Mireille H. G. Indemans, Jan Köster, Sandra Goetze, Jurgen Seppen, Dirk Geerts, Roel van Driel, Rogier Versteeg

Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma mā Jan J. Molenaar, Marli E. Ebus, Jan Köster, Peter van Sluis, Carel J.M. van Noesel, Rogier Versteeg, Huib N. Caron

N-ras mutations in human cutaneous melanoma from sun-exposed body sites. mā Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells mā Jan J. Molenaar, Marli E. Ebus, Dirk Geerts, Jan Köster, Fieke Lamers, Linda J. Valentijn, Ellen M. Westerhout, Rogier Versteeg, Huib N. Caron

Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. mā Rogier Versteeg, K M Krüse-Wolters, Arianne C. Plomp, A. van Leeuwen, Nico J. Stam, Hidde L. Ploegh, D. J. Ruiter, Peter I. Schrier

Functional MYCN signature predicts outcome of neuroblastoma irrespective of <i>MYCN</i> amplification mā Linda J. Valentijn, Jan Köster, Franciska Haneveld, Rachida Ait Aissa, Peter van Sluis, Marloes E.C. Broekmans, Jan J. Molenaar, Johan van Nes, Rogier Versteeg

Ngā utauta rapu:

Ngā marau whai pānga